Disease latency refers to the interval between an increment of exposure and a subsequent change in an individual’s risk. This implies that the risk from a certain exposure history does not depend on cumulative exposure alone, but on the timing of exposure. It can be expected that risk varies over time in
Typescript (photocopy).This dissertation generalizes the hazard rate in the Hartley-Sielken model fr...
International audienceAbstractEstimation of the number of expected years of life free of some diseas...
International audienceAbstractEstimation of the number of expected years of life free disease lost d...
The effect of an increment of exposure on disease risk may vary with time since exposure. If the pat...
Background Different approaches have been proposed to investigate latency in epidemiologic studies w...
Lagging exposure information is often undertaken to allow for a latency period in cumulative exposur...
In longitudinal pharmacoepidemiology studies, exposures may be chronic over a period of time and the...
Information on the distribution of lag duration between exposure or intervention and the subsequent ...
Exposure lagging and exposure-time window analysis are 2 widely used approaches to allow for inducti...
Lagging exposure information is often undertaken to allow for a latency period in cumulative exposur...
Lifetime data often arises in the form of multiple events times for a sample of individuals. In such...
Detailed historical data are elicited often from subjects in retrospective studies, yielding time-de...
In biomedical research, a health effect is frequently associated with protracted exposures of varyin...
associations with distributed lag non-linear models Antonio Gasparrini*† In biomedical research, a h...
International audienceAbstract : Quality of life is a central concern in medicine.Thus estimation of...
Typescript (photocopy).This dissertation generalizes the hazard rate in the Hartley-Sielken model fr...
International audienceAbstractEstimation of the number of expected years of life free of some diseas...
International audienceAbstractEstimation of the number of expected years of life free disease lost d...
The effect of an increment of exposure on disease risk may vary with time since exposure. If the pat...
Background Different approaches have been proposed to investigate latency in epidemiologic studies w...
Lagging exposure information is often undertaken to allow for a latency period in cumulative exposur...
In longitudinal pharmacoepidemiology studies, exposures may be chronic over a period of time and the...
Information on the distribution of lag duration between exposure or intervention and the subsequent ...
Exposure lagging and exposure-time window analysis are 2 widely used approaches to allow for inducti...
Lagging exposure information is often undertaken to allow for a latency period in cumulative exposur...
Lifetime data often arises in the form of multiple events times for a sample of individuals. In such...
Detailed historical data are elicited often from subjects in retrospective studies, yielding time-de...
In biomedical research, a health effect is frequently associated with protracted exposures of varyin...
associations with distributed lag non-linear models Antonio Gasparrini*† In biomedical research, a h...
International audienceAbstract : Quality of life is a central concern in medicine.Thus estimation of...
Typescript (photocopy).This dissertation generalizes the hazard rate in the Hartley-Sielken model fr...
International audienceAbstractEstimation of the number of expected years of life free of some diseas...
International audienceAbstractEstimation of the number of expected years of life free disease lost d...